AI & Clinical Trials: Poised for Disruption

Posted by Arun Shastri on Wed, Sep 11, 2019

This blog post is the third in a series on the impact that AI will have on different business aspects of pharma.

We always tell our clients to start small with AI. As Pratap Khedkar shared in my first interview, it’s important to start with clear, specific use cases. For some aspects of the business, it may take some time to carefully consider what these specific use cases are and what opportunities AI can create. Clinical trials present no such difficulties. The opportunities to improve efficiencies are numerous and clear, and AI has begun to make an impact. The industry is aware of the inefficiencies that abound in clinical trial design and execution and is eager to solve them.


>
Read More

The Evolution of the Patient Experience

Posted by Ian Wilcox on Wed, Aug 28, 2019

With the healthcare business model constantly evolving, and new technologies continuously being adopted, the pharmaceutical landscape and the role of healthcare providers is sure to look radically different a few decades down the line.

I recently spoke with Dr. Roland Turck, managing partner of international biotech consulting firm TurckBio, about some of the biggest trends impacting pharma today, from AI to scientific advancements to bridging the divide between medical and commercial. Here are his thoughts on how the industry will evolve for patients and providers. 


>
Read More

AI & Product Launch: Meeting the Need for Speed

Posted by Arun Shastri on Wed, Aug 07, 2019

This blog post is the second in a series on the impact that AI will have on different business aspects of pharma.

AI is changing the way we do business. In my last post, I sat down with Pratap Khedkar to discuss AI’s role across the industry. Now that we’ve been introduced to AI and pharma, we can get more specific.

All aspects of the pharmaceutical organization are striving for increased efficiency and effectiveness by leveraging AI. As we pointed out in our previous post, there’s been more excitement in R&D because of how much data is available from clinical trials and consumer activity. But because of the focus on R&D, many commercial uses of AI have been underserved. One of those areas is product launch.


>
Read More

Innovation Is Healthcare’s New Normal

Posted by Pratap Khedkar on Fri, Aug 02, 2019

Sometimes it’s hard to keep in mind that healthcare was once considered a stodgy, conservative industry—at least by outsiders. Advances in care development and delivery happened, but the healthcare experience was generally the same as it had been decades before, as were the business models leveraged across the healthcare landscape. We’d grown, maybe not comfortable with, but accepting of the status quo.


>
Read More

AI Will Disrupt the Workforce. Does That Make Andrew Yang Right About UBI?

Posted by Arun Shastri on Thu, Aug 01, 2019

A businessman turned politician calls for insurance against job losses in a quickly changing America. His own experience in business pits him against an indifferent Washington, D.C., as he becomes the lone voice of a single issue. Eventually, he decides to run for president. Who is this man? Jacob Coxey.


>
Read More